In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Estee Lauder FY 1996 third quarter net income up 37.6% to $28.2 mil. on sales of $763.9 mil..

This article was originally published in The Rose Sheet

Executive Summary

ESTEE LAUDER NET INCOME UP 37.6% TO $28.2 MIL. IN THIRD QUARTER FY 1996 (ended March 31) on sales of $763.9 mil., an 8.7% increase over the prior year, the firm announced April 30. Excluding the impact of foreign currency, net sales grew 10%. The company highlighted the performance of its U.S. divisions, each of which "achieved double-digit retail sales growth during the quarter" as well as "market share gains." Estee Lauder also cited new product introductions and the "continued success" of its established brands as reasons behind the sales growth

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002764

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel